We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 67

States Regulating PFAS in Food Packaging: What You Need to Know Now
  • Pepper Hamilton LLP
  • USA
  • April 12 2018

Last month, Washington state enacted a new law, making it the first in the country to ban the use of perfluoroalkyl and polyfluoroalkyl substances, or


Regulation of Cosmetics: Is Increased FDA Oversight on the Horizon?
  • Pepper Hamilton LLP
  • USA
  • November 28 2017

The cosmetics industry is booming. In 2016, sales of beauty products climbed to more than $400 billion, and that number likely will keep growing


Aligning a Product's Marketing, Regulatory and IP Plans
  • Pepper Hamilton LLP
  • USA
  • September 8 2017

Patent protection can be critical for health care products, including medical devices, prescription drugs, dietary supplements and software as a


FDA and FTC Solicit Consumer Complaints About Dietary Supplement Marketing
  • Pepper Hamilton LLP
  • USA
  • August 7 2017

The Food and Drug Administration and the Federal Trade Commission have jointly requested that consumers report dietary supplements that "didn't work


FDA Creates Uncertainty by Delaying Nutrition Facts Label Compliance
  • Pepper Hamilton LLP
  • USA
  • July 19 2017

Client Alert FDA finalized the terms of the new Nutrition Facts Label in May 2016 and set a compliance deadline of July 26, 2018. The new label


Supreme Court Affords Greater Leeway to Biosimilars in the 'Patent Dance'
  • Pepper Hamilton LLP
  • USA
  • June 22 2017

In a recent ruling, the U.S. Supreme Court clarified what happens when biosimilar applicants do not follow the regulatory framework for disputes with


AIA On-Sale Bar Applies to Publicized Sales, Even When Knowledge of Sale Did Not Disclose the Underlying Invention
  • Pepper Hamilton LLP
  • USA
  • May 30 2017

The Court of Appeals for the Federal Circuit (CAFC) recently construed the on-sale bar provision of 35 U.S.C. 102(a) in a way that will make it


Due Diligence: Calculating the Regulatory Review Period for Patent Term Extension
  • Pepper Hamilton LLP
  • USA
  • May 25 2017

When applying for a patent term extension (PTE), due diligence matters. If an applicant did not act with due diligence during the testing phase or


Not So Simple Math: Calculating the Regulatory Review Period for Patent Term Extension
  • Pepper Hamilton LLP
  • USA
  • May 18 2017

Calculating a drug’s regulatory review period seems like it should be simple. The FDA even states that its regulatory review period determination is


How to Obtain Multiple Patent Term Extensions for a Single Product
  • Pepper Hamilton LLP
  • USA
  • May 9 2017

Everywhere you look, patent term extension (PTE) is described using the “Rule of Ones:” one patent, one product, one PTE. However, the Rule of Ones